Infertility Clinical Trial
Official title:
Sperms Activation by Direct Electrical Shocks on Testis in Infertile Males
Background :
Up to 15 percent of couples are infertile. In up to half of these couples, male infertility
plays a role. Male infertility is due to low sperm production, abnormal sperm function or
blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems,
lifestyle choices and other factors can play a role in causing male infertility.
Methodology :
It is an interventional trial that involved 45 participants with infertility (Oligospermia,
Hypospermia, Asthenozoospermia and Necrozoospermia). All the participants underwent a semen
analysis for his semen count, volume and motility for a sample taken by masturbation. Then I
gave each one of the participants a small device. This device gives an electrical shock up to
5 milliamps. I told each one independently to use this device properly on his testis every
day and come for follow up checking every month.
After the fourth months, I made the final checkup for everyone and records my data and make a
comparison between (before and after) semen analysis.
Introduction :
Up to 15 percent of couples are infertile. (1) This means they aren't able to conceive a
child even though they've had frequent, unprotected sexual intercourse for a year or longer.
In up to half of these couples, male infertility plays a role. Male infertility is due to low
sperm production, abnormal sperm function or blockages that prevent the delivery of sperm.
Illnesses, injuries, chronic health problems, lifestyle choices and other factors can play a
role in causing male infertility. (2,3) Not being able to conceive a child can be stressful
and frustrating, but a number of male infertility treatments are available. The consequences
of infertility are manifold and can include societal repercussions and personal suffering.
Advances in assisted reproductive technologies, such as IVF, can offer hope to many couples
where treatment is available, although barriers exist in terms of medical coverage and
affordability. (4) Electrical shocks are applied in many fields to treat many diseases
especially in psychiatry and mental disorders. Despite its hazards but it can be useful
within range of current (Up to 5 milliamps). In 1 milliamp can cause just a faint tingle,
this tingle increases as the amount of current increasing until it causes a little pain with
5 milliamps. (5,6,7)
Methodology:
It is an interventional trial that involved 45 participants with infertility (Oligospermia,
Hypospermia, Asthenozoospermia and Necrozoospermia) aged (25 - 45 years) and all of them were
married. 5 participants were excluded because they have Aspermia or Azoospermia. After
clarifying the purpose and the mechanism of the study to the participants, all of them signed
a written consent for each one to confirm his agreement to participate in addition to the
little risks that can be brought as result of the trial if there is. The investigator applied
a semen analysis at a licensed laboratory in Dhi Qar, Nassiryah city in the north of Iraq by
many Laboratory assistances under the supervision of an infertility specialist. All the
participants underwent a semen analysis for his semen count, volume and motility for a sample
taken by masturbation. After choosing my participants and selecting their conditions. Then
The investigator gave each one of the participants a small device (Created by an electrical
engineer from Dhi Qar Engineering College). This device gives an electrical shock up to 5
milliamps. The investigator told each one independently to use this device properly on his
testis every day and come for follow up checking every month as follow:
1. The first month: 1 milliamp for the first 15 days and 2 milliamps for the second 15
days.
2. The second month: 3 milliamps.
3. The third month: 4 milliamps. This process continued for four months (1st June - 25th
September, 2019) with regular follow up by semen analysis. After the fourth months, The
investigator made the final checkup for everyone and records my data and make a
comparison between (before and after) semen analysis and the follow up semen analysis
using Statistical Package for the Social Science (SPSS) version 24.
Discussion:
When The investigator compared between the fourth semen analysis results, The investigator
found a clear change and improvement in seminal motility, volume and count. This can be used
in treating patients with infertility by applying a small amount of current on the testis
from outside (taking in consideration the skin and tissues) which can improve the movement
and power of the sperms gradually and it is also painless.
It is also can be used before intercourse time for those who are very hurry to fertilize an
ovum so their chance of getting an embryo will increase. This device can be produced so any
person with infertility (Oligospermia, Hypospermia, Asthenozoospermia and Necrozoospermia)
can get one and use it with instructions to make his sperms more powerful to fertilize an
ovum.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |